143 related articles for article (PubMed ID: 29683226)
1. Low incidence of heparin-induced skin lesions in orthopedic surgery patients with low-molecular-weight heparins.
Schindewolf M; Paulik M; Kroll H; Kaufmann R; Wolter M; Boehncke WH; Lindhoff-Last E; Recke A; Ludwig RJ
Clin Exp Allergy; 2018 Aug; 48(8):1016-1024. PubMed ID: 29683226
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia.
Schindewolf M; Kroll H; Ackermann H; Garbaraviciene J; Kaufmann R; Boehncke WH; Ludwig RJ; Lindhoff-Last E
J Thromb Haemost; 2010 Jul; 8(7):1486-91. PubMed ID: 20128858
[TBL] [Abstract][Full Text] [Related]
3. High incidence of heparin-induced allergic delayed-type hypersensitivity reactions in pregnancy.
Schindewolf M; Gobst C; Kroll H; Recke A; Louwen F; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
J Allergy Clin Immunol; 2013 Jul; 132(1):131-9. PubMed ID: 23726261
[TBL] [Abstract][Full Text] [Related]
4. Should patients be informed about the risk of heparin-induced thrombocytopenia before prolonged low-molecular-weight heparin thromboprophylaxis post-trauma/orthopedic surgery?
Lubenow N; Hinz P; Ekkernkamp A; Greinacher A
Eur J Haematol; 2007 Sep; 79(3):187-90. PubMed ID: 17655709
[TBL] [Abstract][Full Text] [Related]
5. Adverse skin reactions to low molecular weight heparins: frequency, management and prevention.
Wütschert R; Piletta P; Bounameaux H
Drug Saf; 1999 Jun; 20(6):515-25. PubMed ID: 10392668
[TBL] [Abstract][Full Text] [Related]
6. Molecular weight determines the frequency of delayed type hypersensitivity reactions to heparin and synthetic oligosaccharides.
Ludwig RJ; Schindewolf M; Alban S; Kaufmann R; Lindhoff-Last E; Boehncke WH
Thromb Haemost; 2005 Dec; 94(6):1265-9. PubMed ID: 16411404
[TBL] [Abstract][Full Text] [Related]
7. Low allergenic potential with fondaparinux: results of a prospective investigation.
Schindewolf M; Scheuermann J; Kroll H; Garbaraviciene J; Hecking C; Marzi I; Wolter M; Kaufmann R; Boehncke WH; Lindhoff-Last E; Ludwig RJ
Mayo Clin Proc; 2010 Oct; 85(10):913-9. PubMed ID: 20843983
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
Bucci C; Geerts WH; Sinclair A; Fremes SE
Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
[TBL] [Abstract][Full Text] [Related]
9. Risk for heparin-induced thrombocytopenia with unfractionated and low-molecular-weight heparin thromboprophylaxis: a meta-analysis.
Martel N; Lee J; Wells PS
Blood; 2005 Oct; 106(8):2710-5. PubMed ID: 15985543
[TBL] [Abstract][Full Text] [Related]
10. Impact of the patient population on the risk for heparin-induced thrombocytopenia.
Warkentin TE; Sheppard JA; Horsewood P; Simpson PJ; Moore JC; Kelton JG
Blood; 2000 Sep; 96(5):1703-8. PubMed ID: 10961867
[TBL] [Abstract][Full Text] [Related]
11. Delayed-type hypersensitivity skin reactions caused by subcutaneous unfractionated and low-molecular-weight heparins: tolerance of a new recombinant hirudin.
Koch P; Münssinger T; Rupp-John C; Uhl K
J Am Acad Dermatol; 2000 Apr; 42(4):612-9. PubMed ID: 10727306
[TBL] [Abstract][Full Text] [Related]
12. [Potentials risks in drug prevention of thrombosis--low-molecular-weight heparin versus standard heparin].
Ganzer D; Gutezeit A; Mayer G
Z Orthop Ihre Grenzgeb; 1999; 137(5):457-61. PubMed ID: 10549126
[TBL] [Abstract][Full Text] [Related]
13. Delayed-Type Heparin Allergy: Intravenous Tolerance Despite Inflammatory Skin Reaction After Subcutaneous Injection.
Trautmann A; Grän F; Stoevesandt J
J Allergy Clin Immunol Pract; 2022 Nov; 10(11):2977-2983.e1. PubMed ID: 35788063
[TBL] [Abstract][Full Text] [Related]
14. Association of heparin-induced skin lesions, intracutaneous tests, and heparin-induced IgG.
Harenberg J; Huhle G; Wang L; Hoffmann U; Bayerl C; Kerowgan M
Allergy; 1999 May; 54(5):473-7. PubMed ID: 10380778
[TBL] [Abstract][Full Text] [Related]
15. The incidence of heparin-induced thrombocytopenia in medical patients treated with low-molecular-weight heparin: a prospective cohort study.
Prandoni P; Siragusa S; Girolami B; Fabris F;
Blood; 2005 Nov; 106(9):3049-54. PubMed ID: 16030191
[TBL] [Abstract][Full Text] [Related]
16. The incidence of heparin-induced thrombocytopenia in patients treated with low molecular weight heparin for superficial vein thrombosis.
Sartori M; Favaretto E; Migliaccio L; Guazzaloca G; Legnani C; Palareti G; Cosmi B
Thromb Res; 2016 Mar; 139():154-7. PubMed ID: 26916314
[TBL] [Abstract][Full Text] [Related]
17. [Prevention of thromboembolism as a cause of thromboembolic complications. A study of the incidence of heparin-induced thrombocytopenia type II].
Ganzer D; Gutezeit A; Mayer G; Greinacher A; Eichler P
Z Orthop Ihre Grenzgeb; 1997; 135(6):543-9. PubMed ID: 9499523
[TBL] [Abstract][Full Text] [Related]
18. Incidence and diagnosis of heparin-induced thrombocytopenia (HIT) in patients with traumatic injuries treated with unfractioned or low-molecular-weight heparin: a literature review.
Bloemen A; Testroote MJ; Janssen-Heijnen ML; Janzing HM
Injury; 2012 May; 43(5):548-52. PubMed ID: 21640991
[TBL] [Abstract][Full Text] [Related]
19. Low molecular weight heparin-induced skin necrosis-a systematic review.
Handschin AE; Trentz O; Kock HJ; Wanner GA
Langenbecks Arch Surg; 2005 Jun; 390(3):249-54. PubMed ID: 15570433
[TBL] [Abstract][Full Text] [Related]
20. [Erythema after subcutaneous heparin treatment].
Brouns AJ; Jie KS
Ned Tijdschr Geneeskd; 2015; 159():A9304. PubMed ID: 26507065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
